Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
‘A marathon and a sprint at the same time’: How we won $452m damages
Americas
‘A marathon and a sprint at the same time’: How we won $452m damages
With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.   12 December 2024
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
Americas
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using innovation to research therapeutic candidates.   10 December 2024
‘AI curious’ counsel at AZ, Novartis weigh risks and benefits
Americas
‘AI curious’ counsel at AZ, Novartis weigh risks and benefits
Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.   10 December 2024
Americas
Trump’s return sparks calls for pro-patent agenda
As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.   5 December 2024
Americas
EOFlow ordered to pay rival $452m over insulin patch trade secrets
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.   5 December 2024
Americas
WATCH: Korean biopharma's global expansion - evolving patent strategies and regulatory landscape
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past.   4 December 2024
Americas
WATCH: European patent term extension (SPCs)
Speakers from Kilburn & Strode discuss key differences between European SPCs and US PTEs, outlining strategies for maximising protection for pharmaceutical and biologic products in Europe.   4 December 2024
Americas
Amgen faces pushback over bid to narrow patent scope
German biotech asks federal judge to reject Amgen’s efforts to narrow scope of a key patent in ongoing dispute | Patent relates to Lindis' cancer immunotherapy treatment | Lindis calls on court to uphold the broader interpretation and claims Amgen’s attempt to narrow is inconsistent with the patent's history.   3 December 2024
Europe
LSPN Europe: Navigating the EPO and lessons from the UPC frontline
One-day event in London brings in-house counsel and private practitioners together | First sessions to kick off the day covered European Patent Office procedures, and in-house views on how the UPC is faring.   3 December 2024
Careers
Paul Hastings reinforces London office with high-tech patent litigator
Former EIP partner joins IP and technology practice | New London hire is known for high-stakes, cross-border patent litigation.   3 December 2024